Presented by Terance Woodworth, M.S. at the September 9, 2003 meeting of the Anesthetic and Life Support Drugs Advisory Committee.

Slides:

Advertisements

Similar presentations

Trend in Prescription Drug Abuse In 2004, 19.1 million Americans were current illicit drug users (7.9% of the U.S. population) 1 In 2004, 19.1 million.

Advertisements

COMMISSION STATISTICS Claims Continue To Decline 2013 – 10, – 11, – 20,557.

© 2014 Virginia Department of Forensic Science Linda C. Jackson, Director Virginia Department of Forensic Science October 2, 2014 DFS Drug Data Heroin.

Curbing Diversion of Prescription Opioids Nathaniel Katz, MD, MS Tufts University School of Medicine Analgesic Research Opioid Prescribing to Adolescents.

A Growing Problem…. We Will Discuss Prescription vs. OTC medications Alarming trends Myths about prescription drug abuse Specific medications of abuse.

CDER/CSS ALSDAC September 9-10, 2003 Risk Management and the Controlled Substances Act: The FDA Perspective Deborah B. Leiderman, M.D., M.A. Director Controlled.

National Institute on Drug Abuse P rescription D rug A buse: An Escalating Public Health Threat P rescription D rug A buse: An Escalating Public Health.

Pain Policy Update Opioid Update Stuart Beatty, PharmD, BCPS.

Findings from the Drug Abuse Warning Network Narcotic Analgesics Judy K. Ball, Ph.D., M.P.A. Office of Applied Studies, Substance Abuse and Mental Health.

Anesthetic and Life Support Drugs and Drug Safety and Risk Management Advisory Committees November 13 & 14, 2008 Reported Manipulation of Oxycodone Extended-Release.

Anesthetic and Life Support Drugs, and Drug Safety and Risk Management Advisory Committees, November 13, 2008 Outpatient Drug Utilization Trends for Oxycodone.

1 Drug Utilization for Immediate- and Modified Release Opioids in the U.S. Gianna C. Rigoni, Pharm.D., M.S. Epidemiologist Division of Surveillance, Research.

Drug Trends in Washington State & King County Caleb J. Banta-Green MPH MSW Alcohol & Drug Abuse Institute University of Washington

Oxycodone and the Effects of Opioids LAUREN FRAILEY HEALTH 1050.

The South Florida Report January 2013 National Institute on Drug Abuse Community Epidemiology Work Group James N. Hall Report # 56 Center for Applied Research.

Seasonal Adjustment and BEA’s Estimates of GDP and GDI Bob Kornfeld BEA Advisory Committee Meeting May 11 th, 2012.

Anesthetic and Life Support Drugs and Drug Safety and Risk Management Advisory Committees, November 13 & 14, 2008 History of OxyContin: Labeling and Risk.

Commercial (Non Government Sponsored) Health Plan Medical Cost and Premium Trends Pharmaceuticals15%14% 12% 11%1.8% Hospital Inpatient Outpatient2515.

Abuse Liability of Hydromorphone Extended Release Capsules Silvia N. Calderon, Ph.D. Controlled Substance Staff Center for Drug Evaluation and Research.

1 National Estimates from the Drug Abuse Warning Network CAPT Kathy Poneleit United States Public Health Service Office of Applied Studies Substance Abuse.

Summary of Drug Abuse “Rates” in the United States: Focus on Morphine Catherine Dormitzer, PhD, MPH Division of Epidemiology Office of Surveillance and.

Slide 1 Overview of the Drug Formulary Commission and Statutory Objectives Bureau of Health Care Safety and Quality Department of Public Health August.

Office of Diversion Control

Center for Drug Evaluation and Research Patterns of Prescription Weight-Loss Drug Use Endocrinologic and Metabolic Drugs Advisory Committee Meeting Rockville,

1 Mental Health and Substance Abuse Services Division Association of Substance Abuse Providers Mike Maples October 5, 2011.

Ken Saffier, MD, Natasha Pinto, MD And Patients CCRMC/HC Noon Conference February 18, 2010.

Researched Abuse, Diversion, and Addiction-Related Surveillance Sidney H. Schnoll, M.D., Ph.D.

1 One Year Post Exclusivity Adverse Event Review: Ofloxacin Ophthalmic Pediatric Advisory Committee Meeting September 15, 2004 Hari Cheryl Sachs, MD, FAAP.

“Heroin Addiction in Kentucky” Mark Fisher,M.S., SOTA Kentucky.

Opioid Risk Management Programs Celia Jaffe Winchell, M.D. Acting Deputy Division Director Division of Anesthetic, Critical Care, and Addiction Drug Products.

March 2004 Prescription Drug Abuse in the United States.

CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for Substance Abuse Research Sales data from the.

Exhibit 25.1 Annual Percentage Changes in the Prescription Drug Price Index and Prescription Drug Expenditures, Copyright 2011 Health Administration.

Understanding and Using INCB Opioid Consumption Statistics: Including Morphine Equivalence 8 August 2012 Martha Maurer, MSW, MPH, PhD Pain & Policy Studies.

Opiates. Opiates: what, exactly are they?!? Opiates are used to induce sleep and alleviate pain. They act as depressants to the central nervous system.

Drug Abuse Trends in the State of California Presented to: CA Association for Criminal Justice Research March 17, 2005 Presented by: Kiku Annon, MA, WestEd.

Broward County Report Substance Abuse Issues and Trends – Winter 2013 James N. Hall.

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:

1 Findings from the Drug Abuse Warning Network Judy K. Ball, Ph.D., M.P.A. Office of Applied Studies Substance Abuse and Mental Health Services Administration.

Broward Quick Check September 2012 Drug Abuse Patterns and Trends Update James N. Hall, Epidemiologist Center for Applied Research on Substance Use and.

Buprenorphine Treatment for Opioid Dependence CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for.

The National Crisis of Prescription Opiate Abuse: How can the FDA respond? Anesthetic & Life Support Drugs Advisory Committee March 29, 2007 Art Van Zee,MD.

State of the State in outcomes: Prescription drug overdoses Karin A. Mack, PhD Senior Behavioral Scientist Prescription Drug Overdose Team National Center.

The Latest Prescription Trends for Controlled Prescription Drugs

DEA’s Most Wanted: Commonly Diverted Controlled Substances

1 One Year Post Exclusivity Adverse Event Review: Ciprofloxacin Pediatric Subcommittee of the Anti-infective Drugs Advisory Committee Meeting June 9, 2004.

Risk Management of Modified- Release Opiate Analgesics: Palladone Sharon Hertz, M.D. Medical Team Leader, Analgesics Division of Anesthetic, Critical Care,

Increase in Methadone Related Deaths Lon R. Hays, M.D., M.B.A. Greg Davis, M.D.

1 National Estimates from the Drug Abuse Warning Network Judy K. Ball, Ph.D., M.P.A. Office of Applied Studies Substance Abuse and Mental Health Services.

Inside Maine’s Medicine Cabinet. Inside Maine’s Medicine Cabinet: Analysis of the Maine Prescription Monitoring Program, Christina Holt, MD,

Medstat MercuryMD Micromedex PDR Solucient Substance abuse medications: Trends and prescribing patterns by physician specialty November 5, 2007 American.

Findings from the Drug Abuse Warning Network Immediate and Sustained Release Opioid Analgesics Judy K. Ball, Ph.D., M.P.A. Office of Applied Studies, Substance.

Gaston County Opioid Data

M367 pill street value oxycodone drug con edison 15 mg morphine vs 15 mg oxycodone pictures whats the fastest way to clean oxycodone out of your system.

Drug Formulary Commission

*Risk Evaluation and Mitigation Strategy

44334 oblong white pill 30 mg oxycodone m blue 10 mg oxycodone time release niacinamide arthritis quickscreen at home drug test 6 oxycodone acetaminophen.

percocet picture of pill 2632

5mg percocet high which is stronger percocet or tylenol 4 month morphine 30 mg compared to percocet 10 oxycontin 10 mg vs percocet 10mg pink percocet 15mg.

114 h percocet 10 mg oxycodone percocet klonopin and ambien is acetaminophen the same as percocet percocet itching antihistamine vs decongestant enhance.

oxycodone 10mg street price

Oxycontin lethal dose oxycontin in canada reformulated where can i get oxycontin online oxycontin dosage pictures of flowers high effects of oxycontin.

Percocet mg oxycodone percocet for anxiety keeps signs of overdose on percocet percocet stomach pain percocet weight gain 10 mg oxycodone percocet.

World Drug Report 2018.

Сэдэв: Нэмэгдсэн өртгийн албан татвар

Federal Research Institute for Health Organization and Informatics of Ministry of Health of the Russian Federation Policy and substance use among adolescents.

Alabama Community Care –Region A Round Table Discussion

НЭМЭГДСЭН ӨРТГИЙН АЛБАН ТАТВАР БА ТҮҮНИЙ ТӨРЛҮҮД

ආහාර පනත සහ රෙගුලාසි.

Presentation transcript:

Presented by Terance Woodworth, M.S. at the September 9, 2003 meeting of the Anesthetic and Life Support Drugs Advisory Committee

Estimates of U.S. Consumption Morphine (sale) (Kg) ARCOS (sales at the retail level) Year-End Reports (distributions by dosage form manufacturers) IMS Health, IMS National Sales Perspectives™ Extracted August 2003 Aggregate Production Quotas

Estimates of U.S. Consumption Hydrocodone (sale) (Kg) ARCOS (sales at the retail level) Year-End Reports (distributions by dosage form manufacturers) IMS Health, IMS National Sales Perspectives™ Extracted August 2003 Aggregate Production Quotas

Estimates of U.S. Consumption Oxycodone (sale) (Kg) ARCOS (sales at the retail level) Year-End Reports (distributions by dosage form manufacturers) IMS Health, IMS National Sales Perspectives™ Extracted August 2003 ( total kg dispensed) Aggregate Production Quotas

Consequences of Increased Availability Morphine Drug Abuse Warning Network IMS Health, National Prescription Audit Plus™ (DAWN Emergency Department Mentions) Total Prescriptions Dispensed (per 100,000 pop.) DAWN Mentions per 100,000 scripts

Consequences of Increased Availability Hydrocodone (DAWN Emergency Department Mentions) Drug Abuse Warning Network I MS Health, National Prescription Audit Plus™ 40,000 32,000 24,000 16,000 8,000 0 Total Prescriptions Dispensed (per 100,000 pop.) DAWN Mentions per 100,000 scripts

Consequences of Increased Availability Oxycodone (DAWN Emergency Department Mentions) 15,000 12,000 9,000 6,000 3,000 0 Total Prescriptions Dispensed (per 100,000 pop.) Drug Abuse Warning Network IMS Health, National Prescription Audit Plus™ DAWN Mentions per 100,000 scripts

Morphine Hydrocodone Oxycodone Consequences of Increased Availability DAWN Mentions per 100,000 scripts Linear Regression Trend line Attachment G

State and Local Seizures of Opioids Source: National Forensic Laboratory Information System (NFLIS) * * As of 8/27/03 Attachment H

Promotional Expenditures vs Dollar Sales IMS IPS and NSP Audits* $0 $200,000 $400,000 $600,000 $800,000 $1,000,000 $1,200,000 $1,400,000 $1,600,000 $1,800,000 Actiq Avinza Duragesic Kadian MSContin OxyContin Dollars in Thousands 2002 Total Promotional Dollars 2002 Total Dollars Sales NSP *IMS Health, IMS National Sales Perspectives™, Extracted August 2003 IMS Health, Integrated Promotional Services Audit™, Extracted August 2003